Close

H.C. Wainwright Starts AcelRx Pharma (ACRX) at Buy, PT $8.50

September 2, 2015 7:41 AM EDT Send to a Friend
H.C. Wainwright initiated coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX) with a Buy rating and a price target of $8.50. Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login